During the past decade, Hospital Universitari i Politècnic La Fe | Cardiología conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari i Politècnic La Fe | Cardiología" are "Pulmonary Arterial Hypertension" (2 trials), "Atrial Fibrillation" (1 trials), "Chronic Heart Failure" (1 trials), "Heart Failure" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Hospital Universitari i Politècnic La Fe | Cardiología" in a lesser frequency.

Most popular intervention types in "Hospital Universitari i Politècnic La Fe | Cardiología" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari i Politècnic La Fe | Cardiología" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitari i Politècnic La Fe | Cardiología". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital Universitari i Politècnic La Fe | Cardiología, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari i Politècnic La Fe | Cardiología, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".